← Back to Search

Aromatherapy for Cancer-Related Nausea and Anxiety

N/A

Waitlist Available

Led By Mary Lyons, MSN, APN/CNS, RN-BC, ONC

Research Sponsored by Central DuPage Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Women of non-childbearing potential or with childbearing potential with a negative pregnancy test documented during the hospital stay

Age 18 years or greater

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24hrs post aromatherapy

Awards & highlights

Study Summary

This trial will test whether aromatherapy can help cancer patients with nausea or anxiety.

Who is the study for?

This trial is for adults over 18 who speak English and are hospitalized with cancer at Central DuPage Hospital. They must understand aromatherapy, not be pregnant (or have a negative pregnancy test), and experience nausea, vomiting or anxiety. It's not for those under 18, prisoners, severely cognitively impaired, allergic to lavender or peppermint, or non-English speakers.Check my eligibility

What is being tested?

The study tests if inhaling peppermint oil can help with nausea/vomiting and lavender oil with anxiety in oncology patients. Participants will use these oils and then answer a questionnaire about how effective they found the treatment and their willingness to use it again.See study design

What are the potential side effects?

Potential side effects may include allergic reactions to the essential oils used—peppermint or lavender—which could manifest as skin irritation or respiratory issues among sensitive individuals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am not able to have children or I can and have a negative pregnancy test.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24hrs post aromatherapy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24hrs post aromatherapy

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24hrs post aromatherapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Post Intervention Patient Interview Form

Trial Design

1Treatment groups

Experimental Treatment

Group I: Peppermint and Lavender Essential OilsExperimental Treatment1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Central DuPage HospitalLead Sponsor

13 Previous Clinical Trials

3,405 Total Patients Enrolled

Mary Lyons, MSN, APN/CNS, RN-BC, ONCPrincipal InvestigatorCentral DuPage Hospital

Media Library

Peppermint and Lavender Essential Oils Clinical Trial Eligibility Overview. Trial Name: NCT02163369 — N/A

Nausea and Vomiting Research Study Groups: Peppermint and Lavender Essential Oils

Nausea and Vomiting Clinical Trial 2023: Peppermint and Lavender Essential Oils Highlights & Side Effects. Trial Name: NCT02163369 — N/A

Peppermint and Lavender Essential Oils 2023 Treatment Timeline for Medical Study. Trial Name: NCT02163369 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts underway for this experiment?

"According to clinicaltrials.gov, this particular study is not presently enrolling participants. It was first advertised on July 1st 2014 and last updated February 3rd 2015. Nonetheless, 98 other medical trials are currently admitting patients into their experiments."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Use of Aromatherapy for Symptom Management

2014. "The Use of Aromatherapy for Symptom Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02163369.

All > Paid Studies Illinois